US Patent Issued to UNIVERSITAT FUR BOEDENKULTUR WIEN, MEDIZINESCHE UNIVERSITAT WIEN on Nov. 3 for "Recombinant human diamine oxidase and methods for treatment of excess histamine conditions using the same" (Austrian Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,202, issued on Nov. 3, was assigned to UNIVERSITAT FUR BOEDENKULTUR WIEN (Vienna) and MEDIZINESCHE UNIVERSITAT WIEN (Vienna).

"Recombinant human diamine oxidase and methods for treatment of excess histamine conditions using the same" was invented by Thomas Bohm (Vienna), Bernd Jilma (Vienna), Nicole Borth (Vienna) and Elisabeth Gludovacz (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention refers to a recombinant human diamine oxidase (DAO) with decreased glycosaminoglycan binding affinity, wherein said DAO comprises at least one amino acid modification in the glycosaminoglycan (GAG) binding domain. The present invention also refers t...